FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

LENZ BRIAN 		2. Issuer Name and Ticker or Trading Symbol

VioQuest Pharmaceuticals, Inc. [ VQPH ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CFO and Treasurer
(Last)          (First)          (Middle)

180 MT. AIRY ROAD, SUITE 102 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/13/2008
(Street)

BASKING RIDGE, NJ 07920
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

6/17/2008 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  1500   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant   $4.00   (1)                 6/29/2007   6/29/2012   Common Stock, $.001 par value   328   (1)   328   (1) D    
Warrant   $1.00   (1)                 4/9/2008   4/9/2013   Common Stock   8333   (1)   8333   (1) D    
Series B Convertible Preferred Stock   $3.80   (1)                 3/14/2008     (8) Series A Convertible Preferred Stock   5     .285   D    
Series A Convertible Preferred Stock   $0.60   (1)                 4/9/2008     (8) Common Stock   8333   (1)   10   D    
Stock Options   $16.70   (1) 6/13/2008     D  (2)       1500   (1)     (2) 10/6/2013   Common Stock   1500   (1) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (2)    1500         (2) 10/6/2013   Common Stock   1500   $0   1500   D    
Stock Options   $14.00   (1) 6/13/2008     D  (3)       2500   (1)     (3) 4/19/2014   Common Stock   2500   (1) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (3)    2500         (3) 4/19/2014   Common Stock   2500   $0   2500   D    
Stock Options   $10.80   (1) 6/13/2008     D  (4)       6000   (1)     (4) 1/24/2015   Common Stock   6000   (1) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (4)    6000         (4) 1/24/2015   Common Stock   6000   $0   6000   D    
Stock Options   $10.30   (1) 6/13/2008     D  (5)       10000   (1)     (5) 11/29/2015   Common Stock   10000   (1) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (5)    10000         (5) 11/29/2015   Common Stock   10000   $0   10000   D    
Stock Options   $8.50   (1) 6/13/2008     D  (6)       10000   (1)     (6) 3/31/2016   Common Stock   10000   (1) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (6)    10000         (6) 3/31/2016   Common Stock   10000   $0   10000   D    
Stock Options   $5.50   (1) 6/13/2008     D  (7)       10000   (1)     (7) 5/11/2007   Common Stock   10000   (1) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (7)    10000         (7) 5/11/2017   Common Stock   10000   $0   10000   D    
Stock Options   $1.20   (1) 6/13/2008     D  (9)       80000   (1) (11)     (9) 2/28/2018   Common Stock   80000   (1) (11) $0   0   D    
Stock Options   $0.54   6/13/2008     A  (9)    80000   (11)        (9) 2/28/2018   Common Stock   80000   (11) $0   80000   (11) D    
Stock Options   $0.54   6/13/2008     A     80000         (10) 6/13/2018   Common Stock   80000   $0   80000   D    

Explanation of Responses:
( 1)  Adjusted to reflect a 1-for-10 reverse stock split effective on 4/25/2008.
( 2)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/6/2003 and is fully vested.
( 3)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 4/19/2004 and is fully vested.
( 4)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 1/24/2005 and is fully vested.
( 5)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 11/29/2005 and provides for vesting in three annual installments beginning on 11/29/06.
( 6)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 3/31/2006 and provides for vesting in three annual installments beginning on 3/31/07.
( 7)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 5/11/2007 and provides for vesting in three annual installments beginning on 5/11/2008.
( 8)  No expiration date.
( 9)  This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 2/28/2008 and provides for vesting in three annual installments beginning on 2/28/09 and is subject to acceleration under certain circumstances.
( 10)  Option vests in three annual installments beginning on 6/13/08.
( 11)  Form amended to correct typographical error.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
LENZ BRIAN
180 MT. AIRY ROAD, SUITE 102
BASKING RIDGE, NJ 07920

CFO and Treasurer

Signatures
/s/ Brian Lenz 7/2/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
VioQuest Pharmaceuticals (CE) (USOTC:VOQP)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more VioQuest Pharmaceuticals (CE) Charts.
VioQuest Pharmaceuticals (CE) (USOTC:VOQP)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more VioQuest Pharmaceuticals (CE) Charts.